REPORTS

Let’s Pullulate and Expand Your Business

Pneumococcal Vaccines Market - Global Professional Analysis and Forecast to 2026

Oct 12, 2019  |  219 PAGES  |  REPORT CODE: CMM206623
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Pneumococcal Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.3% during the forecast period.

This report presents the market size and development trends by detailing the Pneumococcal Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pneumococcal Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pneumococcal Vaccines industry and will help you to build a panoramic view of the industrial development.

Pneumococcal Vaccines Market, By Type:

  • 10- valent PCV

  • 7- valent PCV

  • 13- valent PCV

  • 23- valent PPSV

Pneumococcal Vaccines Market, By Application:

  • Clinics

  • Hospitals

  • Others

Some of the leading players are as follows:

  • GlaxoSmithKline

  • Sanofi Pasteur

  • Merck

  • Pfizer

  • Protein Sciences

  • Novartis

  • BioCSL (Seqirus)

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Pneumococcal Vaccines Market: Technology Type Analysis

  • 4.1 Pneumococcal Vaccines Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Pneumococcal Vaccines Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 10- valent PCV

    • 4.3.2 7- valent PCV

    • 4.3.3 13- valent PCV

    • 4.3.4 23- valent PPSV

5 Pneumococcal Vaccines Market: Product Analysis

  • 5.1 Pneumococcal Vaccines Product Market Share Analysis, 2018 & 2026

  • 5.2 Pneumococcal Vaccines Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Pneumococcal Vaccines Market: Application Analysis

  • 6.1 Pneumococcal Vaccines Application Market Share Analysis, 2018 & 2026

  • 6.2 Pneumococcal Vaccines Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Clinics

    • 6.3.2 Hospitals

    • 6.3.3 Others

7 Pneumococcal Vaccines Market: Regional Analysis

  • 7.1 Pneumococcal Vaccines Regional Market Share Analysis, 2018 & 2026

  • 7.2 Pneumococcal Vaccines Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 GlaxoSmithKline

    • 9.1.1 GlaxoSmithKline Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Sanofi Pasteur

    • 9.2.1 Sanofi Pasteur Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Merck

    • 9.3.1 Merck Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Pfizer

    • 9.4.1 Pfizer Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Protein Sciences

    • 9.5.1 Protein Sciences Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Novartis

    • 9.6.1 Novartis Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 BioCSL (Seqirus)

    • 9.7.1 BioCSL (Seqirus) Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

 

The List of Tables and Figures (Totals 61 Figures and 159 Tables)

  • Figure 10- valent PCV Pneumococcal Vaccines market, 2015 - 2026 (USD Million)

  • Figure 7- valent PCV Pneumococcal Vaccines market, 2015 - 2026 (USD Million)

  • Figure 13- valent PCV Pneumococcal Vaccines market, 2015 - 2026 (USD Million)

  • Figure 23- valent PPSV Pneumococcal Vaccines market, 2015 - 2026 (USD Million)

  • Figure Clinics market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Pneumococcal Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table North America Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table North America Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table North America Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Canada Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Canada Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Europe Pneumococcal Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Europe Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Europe Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Europe Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Germany Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Germany Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table France Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table France Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Italy Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Italy Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Spain Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Spain Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pneumococcal Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table China Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table China Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Japan Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Japan Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table India Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table India Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Pneumococcal Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table MEA Pneumococcal Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table MEA Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table MEA Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table MEA Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Pneumococcal Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Pneumococcal Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Pneumococcal Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Pasteur Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Protein Sciences Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BioCSL (Seqirus) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top